Novartis AG (NVS)
93.09
-0.11
(-0.12%)
USD |
NYSE |
Apr 17, 16:00
93.09
0.00 (0.00%)
After-Hours: 20:00
Novartis 1 Year Total Returns (Daily): -1.18% for April 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 16, 2024 | -1.18% |
April 15, 2024 | 0.10% |
April 12, 2024 | 0.61% |
April 11, 2024 | 2.20% |
April 10, 2024 | 2.35% |
April 09, 2024 | 3.29% |
April 08, 2024 | 2.94% |
April 05, 2024 | 4.57% |
April 04, 2024 | 7.57% |
April 03, 2024 | 5.86% |
April 02, 2024 | 6.50% |
April 01, 2024 | 8.15% |
March 28, 2024 | 10.38% |
March 27, 2024 | 10.22% |
March 26, 2024 | 18.28% |
March 25, 2024 | 18.85% |
March 22, 2024 | 21.85% |
March 21, 2024 | 19.17% |
March 20, 2024 | 19.48% |
March 19, 2024 | 21.62% |
March 18, 2024 | 21.12% |
March 15, 2024 | 22.96% |
March 14, 2024 | 24.06% |
March 13, 2024 | 25.89% |
March 12, 2024 | 28.35% |
Date | Value |
---|---|
March 11, 2024 | 30.41% |
March 08, 2024 | 30.97% |
March 07, 2024 | 28.89% |
March 06, 2024 | 26.15% |
March 05, 2024 | 25.84% |
March 04, 2024 | 25.68% |
March 01, 2024 | 27.08% |
February 29, 2024 | 25.28% |
February 28, 2024 | 26.83% |
February 27, 2024 | 25.84% |
February 26, 2024 | 25.86% |
February 23, 2024 | 25.31% |
February 22, 2024 | 23.78% |
February 21, 2024 | 23.38% |
February 20, 2024 | 23.16% |
February 16, 2024 | 21.65% |
February 15, 2024 | 19.28% |
February 14, 2024 | 18.08% |
February 13, 2024 | 18.17% |
February 12, 2024 | 21.33% |
February 09, 2024 | 22.17% |
February 08, 2024 | 21.75% |
February 07, 2024 | 25.07% |
February 06, 2024 | 26.68% |
February 05, 2024 | 25.79% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-10.86%
Minimum
Jan 25 2022
41.88%
Maximum
Sep 26 2023
8.86%
Average
6.72%
Median
Jul 19 2021
1 Year Total Returns (Daily) Benchmarks
Sandoz Group AG | -- |
Amgen Inc | 9.85% |
AstraZeneca PLC | -5.54% |
Incyte Corp | -28.56% |
MorphoSys AG | 245.2% |